Ceritinib can be a tyrosine kinase inhibitor that selectively and potently inhibits anaplastic lymphoma kinase (ALK). In regular physiology, ALK capabilities as a critical step in the event and performance of anxious system tissue. On the other hand, chromosomal translocation and fusion give rise to an oncogenic form of ALK https://albertz221lwg3.blogoxo.com/profile